T lymphocyte subpopulations in patients with B-cell chronic lymphocyte leukaemia: relationship to infective episodes

E R Copson1, N B Westwood, G Majumdar

  • 1Division of Haematology, United Medical School, London, UK.

Leukemia & Lymphoma
|August 1, 1994
PubMed

Insights

Patients with B-cell chronic lymphocytic leukaemia (B-CLL) show altered T-cells, but higher CD5+ B-cells correlate with frequent infections, suggesting malignant B-cells may cause immune suppression.

Area of Science:

  • Immunology
  • Oncology
  • Hematology

Background:

  • B-cell chronic lymphocytic leukaemia (B-CLL) is linked to increased infection risk.
  • Previous studies noted T-cell abnormalities in B-CLL, but their predictive value for infection remained unclear.

Purpose of the Study:

  • To investigate the relationship between lymphocyte subpopulations and infection incidence in B-CLL patients.
  • To determine if T-cell abnormalities predict infection susceptibility in B-CLL.

Main Methods:

  • Enumeration of lymphocyte subpopulations (T-cell subsets, NK cells, CD5+ B-cells) in 22 B-CLL patients.
  • Patients were grouped based on the number of infectious episodes in the preceding three years.

Main Results:

  • No significant differences in T-cell subsets or NK cells were observed between patient groups with varying infection frequencies.
  • Patients experiencing frequent infections exhibited significantly higher CD5+ B-cell counts.

Conclusions:

  • Numerical alterations in T-cell subpopulations are confirmed in B-CLL but do not predict infection susceptibility.
  • Elevated CD5+ B-cell counts in B-CLL patients with frequent infections suggest potential immunosuppressive activity by malignant B-cells.

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Lymphoid Cells and Tissues01:18

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...